Get up to 90% off - Urjas Oil X
Clomidep (Triko) is a commercial drug that is prescribed in the form of Tablet. It is primarily used for the treatment of Obsessive Compulsive Disorder.
Medical history of the patient along with age and gender determines the dosage of Clomidep (Triko). Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Clomidep (Triko) as well, which are listed below. Normally, these side effects of Clomidep (Triko) are not long lasting and go away when the treatment is finished. However, if these continue for a longer time, consult your doctor right away.
Furthermore, you should know that effect of Clomidep (Triko) is Moderate for pregnant women and Severe for women who are breastfeeding. Further, the section on Clomidep (Triko) related warnings talks about Clomidep (Triko)'s effects on the liver, heart and kidney.
Clomidep (Triko) can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Clomidep (Triko) in conditions like Heart Disease, Coronary Artery Disease (CAD), Suicidal Tendency. Other contraindications of Clomidep (Triko) have been discussed in the sections ahead.
Drug reaction of Clomidep (Triko) with other medicines has been reported. Refer to the list below for further details.
In addition to the above precautions for Clomidep (Triko), it is important to know that it is not safe while driving, and is not habit-forming.
Clomidep (Triko) is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Based on research, the following side effects have been observed when Clomidep (Triko) is used -
Severe
Moderate
Mild
Is the use of Clomidep (Triko) safe for pregnant women?
Clomidep (Triko) may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Clomidep (Triko) again without your doctor's advice.
Is the use of Clomidep (Triko) safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Clomidep (Triko). It should only be taken after medical advice.
What is the effect of Clomidep (Triko) on the Kidneys?
Clomidep (Triko) is completely safe for kidneys.
What is the effect of Clomidep (Triko) on the Liver?
Side effects of Clomidep (Triko) rarely affect the liver.
What is the effect of Clomidep (Triko) on the Heart?
Clomidep (Triko) is rarely harmful for the heart.
Clomidep (Triko) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
If you are suffering from any of the following diseases, you should not take Clomidep (Triko) unless your doctor advises you to do so -
Is this Clomidep (Triko) habit forming or addictive?
Clomidep (Triko) is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Clomidep (Triko). So it is best to avoid driving.
Is it safe?
Yes, but consume Clomidep (Triko) only on doctor's advice.
Is it able to treat mental disorders?
Clomidep (Triko) has been seen to have positive effect on patients with mental disorders.
Interaction between Food and Clomidep (Triko)
It is safe to take Clomidep (Triko) with food.
Interaction between Alcohol and Clomidep (Triko)
Consuming Clomidep (Triko) with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Anafranil® (clomipramine hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 454, 456, 458, 464